Amgen
AMGN
#94
Rank
โ‚ฌ157.15 B
Marketcap
291,86ย โ‚ฌ
Share price
-1.52%
Change (1 day)
13.06%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ8.10 Billion

According to Amgen's latest financial reports the company has โ‚ฌ8.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amgen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ11.50 B16.22%
2023-12-31โ‚ฌ9.89 B14.13%
2022-12-31โ‚ฌ8.67 B22.23%
2021-12-31โ‚ฌ7.09 B-18.02%
2020-12-31โ‚ฌ8.65 B8.82%
2019-12-31โ‚ฌ7.95 B-68.95%
2018-12-31โ‚ฌ25.61 B-26.26%
2017-12-31โ‚ฌ34.73 B-4.06%
2016-12-31โ‚ฌ36.20 B26.15%
2015-12-31โ‚ฌ28.70 B29.16%
2014-12-31โ‚ฌ22.22 B58.18%
2013-12-31โ‚ฌ14.04 B-22.77%
2012-12-31โ‚ฌ18.18 B14.44%
2011-12-31โ‚ฌ15.89 B21.35%
2010-12-31โ‚ฌ13.09 B39.6%
2009-12-31โ‚ฌ9.38 B37.32%
2008-12-31โ‚ฌ6.83 B39.51%
2007-12-31โ‚ฌ4.89 B2.95%
2006-12-31โ‚ฌ4.75 B7.24%
2005-12-31โ‚ฌ4.43 B3.61%
2004-12-31โ‚ฌ4.28 B5.22%
2003-12-31โ‚ฌ4.06 B-8.8%
2002-12-31โ‚ฌ4.46 B48.01%
2001-12-31โ‚ฌ3.01 B40.02%
2000-12-31โ‚ฌ2.15 B62.52%
1999-12-31โ‚ฌ1.32 B681.69%
1998-12-31โ‚ฌ0.16 B-15.89%
1997-12-31โ‚ฌ0.20 B41.23%
1996-12-31โ‚ฌ0.14 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ12.85 B 58.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.15 B 74.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B-52.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚ฌ6.30 B-22.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.39 B-58.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ4.86 B-39.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.92 B 96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.09 B-86.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ8.50 B 4.96%๐Ÿ‡บ๐Ÿ‡ธ USA